Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon Glass

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Chinese Clinical Oncology|January 9, 2024
Case report: durable response of gliomatosis cerebri with concurrent tumor-treating fields (TTFields) and chemoradiotherapy treatmentAlex M DesJarlais, Ryan Miller, Ayesha S Ali, et al.
Cancer|December 20, 2011
Improving prognosis of glioblastoma in the 21st century: who has benefited most?Yaacov Richard Lawrence, Mark V Mishra, Maria Werner-Wasik, et al.
Journal of Neuro-Oncology|January 21, 2014
Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiformeColin E Champ, Joshua D Palmer, Jeff S Volek, et al.
Brain Tumor Pathology|January 9, 2014
Primary central nervous system Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a clinicopathologic study of five casesSiraj El Jamal, Shiyong Li, Renu Bajaj, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|January 11, 2020
Clinical Features Predictive of Survival in Patients With Vitreoretinal Lymphoma: Analysis of 70 Patients at a Single Ocular Oncology CenterLauren A Dalvin, Li-Anne S Lim, David Ancona-Lezama, et al.
Cancer|June 8, 2011
A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignanciesEvan J Wuthrick, Mitchell Kamrava, Walter J Curran, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 4, 2019
Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomasAndrew Song, David W Andrews, Maria Werner-Wasik, et al.
Seminars in Oncology|June 29, 2013
A 60-year-old Indian male with altered sensorium and extensive lymphoma of the scalpBudhi S Yadav, Anshuma Bansal, Suresh C Sharma, et al.
Journal of Neuro-Oncology|May 31, 2015
Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always betterJoshua D Palmer, Joshua Siglin, Kosj Yamoah, et al.
International Journal of Radiation Oncology, Biology, Physics|August 9, 2014
A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade gliomaEvan J Wuthrick, Walter J Curran, Kevin Camphausen, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Chinese Clinical Oncology|January 9, 2024
Case report: durable response of gliomatosis cerebri with concurrent tumor-treating fields (TTFields) and chemoradiotherapy treatmentAlex M DesJarlais, Ryan Miller, Ayesha S Ali, et al.
Cancer|December 20, 2011
Improving prognosis of glioblastoma in the 21st century: who has benefited most?Yaacov Richard Lawrence, Mark V Mishra, Maria Werner-Wasik, et al.
Journal of Neuro-Oncology|January 21, 2014
Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiformeColin E Champ, Joshua D Palmer, Jeff S Volek, et al.
Brain Tumor Pathology|January 9, 2014
Primary central nervous system Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a clinicopathologic study of five casesSiraj El Jamal, Shiyong Li, Renu Bajaj, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|January 11, 2020
Clinical Features Predictive of Survival in Patients With Vitreoretinal Lymphoma: Analysis of 70 Patients at a Single Ocular Oncology CenterLauren A Dalvin, Li-Anne S Lim, David Ancona-Lezama, et al.
Cancer|June 8, 2011
A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignanciesEvan J Wuthrick, Mitchell Kamrava, Walter J Curran, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 4, 2019
Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomasAndrew Song, David W Andrews, Maria Werner-Wasik, et al.
Seminars in Oncology|June 29, 2013
A 60-year-old Indian male with altered sensorium and extensive lymphoma of the scalpBudhi S Yadav, Anshuma Bansal, Suresh C Sharma, et al.
Journal of Neuro-Oncology|May 31, 2015
Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always betterJoshua D Palmer, Joshua Siglin, Kosj Yamoah, et al.
International Journal of Radiation Oncology, Biology, Physics|August 9, 2014
A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade gliomaEvan J Wuthrick, Walter J Curran, Kevin Camphausen, et al.
Pageof 4